Edit search
%2525255BAngiogenesis inhibitors for the systemic treatment …
%2525255BAngiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma%2525253A sunitinib%2525252C sorafenib%2525252C bevacizumab and temsirolimus%2525255D
%2525255BAngiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma%2525253A sunitinib%2525252C sorafenib%2525252C bevacizumab and temsirolimus%2525255D
Article, Chapter
Authors: P.H.M. de Mulder
Publication: Volume:152, Page(s):371
Published: 2008
Browse related articles
  Request a copy of this item
Cite this item